[go: up one dir, main page]

GB2346971B - Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins - Google Patents

Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins

Info

Publication number
GB2346971B
GB2346971B GB9903764A GB9903764A GB2346971B GB 2346971 B GB2346971 B GB 2346971B GB 9903764 A GB9903764 A GB 9903764A GB 9903764 A GB9903764 A GB 9903764A GB 2346971 B GB2346971 B GB 2346971B
Authority
GB
United Kingdom
Prior art keywords
eye lens
blood test
prion protein
antibodies raised
infectious prion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9903764A
Other versions
GB2346971A (en
GB9903764D0 (en
Inventor
Audrey Ann Coop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB9903764A priority Critical patent/GB2346971B/en
Publication of GB9903764D0 publication Critical patent/GB9903764D0/en
Publication of GB2346971A publication Critical patent/GB2346971A/en
Application granted granted Critical
Publication of GB2346971B publication Critical patent/GB2346971B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
GB9903764A 1999-02-19 1999-02-19 Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins Expired - Fee Related GB2346971B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9903764A GB2346971B (en) 1999-02-19 1999-02-19 Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9903764A GB2346971B (en) 1999-02-19 1999-02-19 Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins

Publications (3)

Publication Number Publication Date
GB9903764D0 GB9903764D0 (en) 1999-04-14
GB2346971A GB2346971A (en) 2000-08-23
GB2346971B true GB2346971B (en) 2004-07-21

Family

ID=10848054

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9903764A Expired - Fee Related GB2346971B (en) 1999-02-19 1999-02-19 Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins

Country Status (1)

Country Link
GB (1) GB2346971B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1437144A1 (en) * 2003-01-09 2004-07-14 IVPT Gmbh Rapid in-vivo test for Transmissible Spongiform Encephalopathy in the eye

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US646295A (en) * 1899-05-18 1900-03-27 Alex W R Maas Folding fowl-coop.
EP0074770A1 (en) * 1981-09-04 1983-03-23 Kabushiki Kaisha Yakult Honsha Camptothecin-1-oxide derivatives, process for preparing same, formulations comprising said derivatives and said derivatives for use in producing an anti-tumour effect
EP0444856A2 (en) * 1990-02-26 1991-09-04 Albert Einstein College Of Medicine Of Yeshiva University Diagnostic assay for Alzheimer's disease
WO1993023432A1 (en) * 1992-05-15 1993-11-25 New York University Soluble prion polypeptides, and methods for detecting and purifying thereof
WO1997010505A1 (en) * 1995-09-14 1997-03-20 The Regents Of The University Of California ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc¿
WO1998031824A1 (en) * 1997-01-21 1998-07-23 Macquarie Research Ltd. Fluorescent dyes from microorganisms
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US646295A (en) * 1899-05-18 1900-03-27 Alex W R Maas Folding fowl-coop.
EP0074770A1 (en) * 1981-09-04 1983-03-23 Kabushiki Kaisha Yakult Honsha Camptothecin-1-oxide derivatives, process for preparing same, formulations comprising said derivatives and said derivatives for use in producing an anti-tumour effect
EP0444856A2 (en) * 1990-02-26 1991-09-04 Albert Einstein College Of Medicine Of Yeshiva University Diagnostic assay for Alzheimer's disease
WO1993023432A1 (en) * 1992-05-15 1993-11-25 New York University Soluble prion polypeptides, and methods for detecting and purifying thereof
WO1997010505A1 (en) * 1995-09-14 1997-03-20 The Regents Of The University Of California ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc¿
WO1998031824A1 (en) * 1997-01-21 1998-07-23 Macquarie Research Ltd. Fluorescent dyes from microorganisms
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions

Also Published As

Publication number Publication date
GB2346971A (en) 2000-08-23
GB9903764D0 (en) 1999-04-14

Similar Documents

Publication Publication Date Title
ATE198491T1 (en) SYSTEM FOR EXPRESSING HETEROLOGUE ANTIGENS AS FUSION PROTEINS
DK1366067T3 (en) EXPRESSION TECHNOLOGY FOR PROTEINS CONTAINING A HYBRID ISOTYPE ANTIBODY UNIT
NO980915D0 (en) Recombinant anti-CD4 antibody suitable for human therapy
DK0699687T3 (en) Process for purifying recombinant human serum albumin
AU1701001A (en) Antibodies against signal regulator proteins
AU2002364586A8 (en) Albumin fusion proteins
HUP0302681A3 (en) Javelinization of protein antigens to heat shock proteins
NO980566D0 (en) Allergen-XCD32 fusion proteins
EP1543767A4 (en) SYSTEM FOR MEASURING EYE CHARACTERISTICS
EP1146333A4 (en) METHOD FOR SEPARATING HEMOGLOBIN A2
NO20021275D0 (en) Transgent produced fusion proteins
GB2346971B (en) Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins
AU2001291050A1 (en) Viral chemokine-tumur antigen fusion proteins
AU2002232803A1 (en) Expression system for recombinant proteins
AU2003298827A1 (en) Methods for preparing antigen masked red blood cells having reduced hemolysis by sera
AU7709000A (en) Methods for producing recombinant proteins
AU2002211611A1 (en) Polyvalent cation-sensing receptor proteins in aquatic species
DE60040903D1 (en) AMINO ACIDS CONTAINING ALBUMIN PREPARATIONS
AU2001286303A1 (en) Recombinant fusion protein for diagnosis of tsutsugamushi disease
AU1087199A (en) Human vesicle membrane protein-like proteins
AU2003226907A8 (en) Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
AU1216988A (en) Immunogenic fusion proteins which contain Epstein-Barr virus protein
AU3452700A (en) Antibodies to placental protein 13
NO20021244D0 (en) Subunit-optimized fusion proteins
AU2002344252A1 (en) Mammalian diabetes-mediating proteins

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20140219